1) "Immune
correlates of metastatic melanoma patients treated with
ipilimumab in combination with fotemustine in the phase II
NIBIT-M1 study" SITC 28th Annual Meeting, being held
November 8-10, 2013 at the Gaylord National Hotel &
Convention Center in National Harbor, MD.
|